• Giuseppe Argenziano, Paolo Amerio, Maria Grazia Aragone, Ginevra Baggini, Manuela Baldari, Gianpiero Castelli, Simmaco Coppola, Antonio Costanzo, Rocco De Pasquale, Maria Concetta Fargnoli, Caterina Foti, Claudia Giofrè, Serena Lembo, Claudia Leporati, Francesco Loconsole, Giovanna Malara, Ketty Peris, Antonio Giovanni Richetta, Paola Savoia, Rossana Tiberio, Massimo Travaglini, Maria Teresa Uzzauto, and Luca Bianchi.
• Dermatology Unit, University of Campania, Naples, Italy.
• Patient Prefer Adher. 2021 Jan 1; 15: 2551-2562.

PurposeFor patients with psoriasis, treatment adherence and persistence are fundamental if therapeutic goals are to be met. Patient Support Programs (PSPs) may be used as a support tool to assist patients and health care professionals optimize treatment and improve disease management.Patients And MethodsIn Italy, the PSP PSOLife CARE, which began on the 9th of February 2017 and is ongoing, aimed to support patients with psoriasis under therapy with secukinumab (Cosentyx®). A team of medical professionals including Dermatologists, Psychologists, Nutritionists, and field Nurses provided outpatient treatment as well as remote support via phone calls. Patients had a standard duration in the Program of 6 months. This report analyzes the data of patients who benefited from the Program from February 2017 to August 2020, for a total observation of 42 months.ResultsWe provide here a descriptive report on the benefits of participation in the PSOLife CARE Program for patients with psoriasis and medical professionals involved in their care. Throughout their time in the PSOLife CARE Program, patient satisfaction remained consistently high with sustained improvements observed in all aspects of quality of life (ie emotional, social, physical, and economic). Despite exiting from the Program, most patients continued to adhere to secukinumab. Medical professionals also reported positive outcomes on their interactions with patients, with more than half of those surveyed rating the overall quality of the Program as "Outstanding".ConclusionBy supporting treatment adherence, the PSOLife CARE Program may have empowered patients to better manage their psoriasis, increasing their satisfaction with treatment and quality of life.© 2021 Argenziano et al.

3 keywords...

hide…